首页> 美国卫生研究院文献>Nutrients >Impact of Enhanced Recovery after Surgery with Preoperative Whey Protein-Infused Carbohydrate Loading and Postoperative Early Oral Feeding among Surgical Gynecologic Cancer Patients: An Open-Labelled Randomized Controlled Trial
【2h】

Impact of Enhanced Recovery after Surgery with Preoperative Whey Protein-Infused Carbohydrate Loading and Postoperative Early Oral Feeding among Surgical Gynecologic Cancer Patients: An Open-Labelled Randomized Controlled Trial

机译:术前注入乳清蛋白的碳水化合物载量和术后妇科癌症患者术后早期口服喂养后手术恢复增强的影响:开放式随机对照试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Enhanced Recovery after Surgery (ERAS) with sole carbohydrate (CHO) loading and postoperative early oral feeding (POEOF) hortened the length of postoperative (PO) hospital stays (LPOHS) without increasing complications. This study aimed to examine the impact of ERAS with preoperative whey protein-infused CHO loading and POEOF among surgical gynecologic cancer (GC) patients. There were 62 subjects in the intervention group (CHO-P), which received preoperative whey protein-infused CHO loading and POEOF; and 56 subjects formed the control group (CO), which was given usual care. The mean age was 49.5 ± 12.2 years (CHO-P) and 51.2 ± 11.9 years (CO). The trial found significant positive results which included shorter LPOHS (78.13 ± 33.05 vs. 99.49 ± 22.54 h); a lower readmission rate within one month PO (6% vs. 16%); lower weight loss (−0.3 ± 2.3 kg vs. −2.1 ± 2.3 kg); a lower C-reactive protein–albumin ratio (0.3 ± 1.2 vs. 1.1 ± 2.6); preserved muscle mass (0.4 ± 1.7 kg vs. −0.7 ± 2.6 kg); and better handgrip strength (0.6 ± 4.3 kg vs. −1.9 ± 4.7 kg) among CHO-P as compared with CO. However, there was no significant difference in mid-upper arm circumference and serum albumin level upon discharge. ERAS with preoperative whey protein-infused CHO loading and POEOF assured better PO outcomes.
机译:单一碳水化合物(CHO)负荷和术后早期早期口服喂养(POEOF)增强了术后恢复(ERAS),缩短了术后(PO)住院时间(LPOHS)的时间,而没有增加并发症的发生。这项研究旨在检查ERAS与术前注入乳清蛋白的CHO负荷和POEOF对外科妇科癌症(GC)患者的影响。干预组(CHO-P)有62名受试者,接受术前注入乳清蛋白的CHO负荷和POEOF。 56名受试者组成对照组(CO),接受常规护理。平均年龄为49.5±12.2岁(CHO-P)和51.2±11.9岁(CO)。该试验发现了显着的积极结果,包括较短的LPOHS(78.13±33.05 vs. 99.49±22.54 h);一个月内PO的重新录取率较低(6%对16%);更低的体重减轻(-0.3±2.3公斤vs -2.1±2.3公斤);较低的C反应蛋白-白蛋白比率(0.3±1.2与1.1±2.6);保留肌肉质量(0.4±1.7公斤vs -0.7±2.6公斤);与CO相比,CHO-P具有更好的握力(0.6±4.3 kg vs. -1.9±4.7 kg)。但是,出院时上臂中围和血清白蛋白水平没有显着差异。术前使用乳清蛋白灌注的CHO负荷和POEOF的ERAS确保了更好的PO结局。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号